Renova review

Renova, which is generically prescribed as tretinoin topical, is commonly used to treat the signs of aging of overexposure to the sun such as, fine wrinkles, skin roughness, and blotted discolorations.

Renova is not appropriate for everyone. A thorough medical history should be assessed prior to prescribing this medication. Patients with a medical history which includes skin allergies, skin sensitivities, or acne or any other form of skin infections or sores on the face may not be able to take Renova or may require careful monitoring while undergoing drug therapy with this medication, depending on the condition and the severity of the condition.

The American Food and Drug Administration rated Renova as a pregnancy risk category C. Renova has been proven to carry a risk of causing harm or birth defects to an unborn baby. This medication has been proven to pass through the mother’s breast milk and may affect a nursing baby. The prescribing physician should avoid use of this medication for women who are pregnant, nursing, or who have a high likelihood of becoming pregnant.

There is a risk of side effects associated with Renova, some of which are severe. A patient who is experiencing a serious side effect or an allergic reaction should seek immediate emergency medical attention. An allergic reaction will present with side effects such as facial swelling, including swelling of the lips, mouth, throat, or tongue, hives, and difficulty breathing. Other serious side effects which require immediate emergency medical attention include symptoms such as any skin sensation that feels intolerable or severe like burning or stinging.

Less serious side effects typically do not require emergency medical attention but should be reported to the prescribing physician. Patients should be encouraged to report all side effects. Less serious side effects include symptoms such as burning, stinging, skin discoloration, warmth, tingling, itching, redness, swelling, dryness, peeling, or irritation. Less serious side effects can often be reduced to a tolerable level by reducing the dosage of Renova.

Renova should be taken exactly as it has been prescribed by the physician. If the patient misses a dose, the dose should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped to avoid the potential for an overdose. The patient should never take a double dose of this medication. If an overdose is suspected, the patient should seek immediate emergency medical attention. An overdose will present with symptoms such as severe peeling of the skin that may lead to possible scarring, intense sensations that are intolerable such as burning or stinging.

There is a potential risk of negative drug interactions associated with Renova. A thorough medical history should be understood prior to prescribing this medication. Patients should be urged to inquire with the prescribing physician before taking any new medications, including over the counter medications and herbal remedies. Medications with a known negative drug interactions with Renova include tetracycline, diuretics, antibiotics, sulfa drugs, and chlorpromazine. Patients should be encouraged to be particularly cautious when exposed to the sun, as severe sunburn may occur as sensitivity to sunlight typically increases with the use of Renova. Patients should avoid topical skin care products as well as harsh cleansers and facial applications. Cosmetics may increase irritation.

Renova has the following structural formula:

Chemical structure of renova

• Molecular formula of renova is C20H28O2
• Chemical IUPAC Name is 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-nona-2,4,6,8-tetraenoic acid
• Molecular weight is 300.435 g/mol
Renova available : 0.02% cream

Generic name: Alitretinoin

Brand name(s): Avita, Beta-retinoic acid, Panretin, Panretyn, Panrexin, Retin-A, Retinoate, Retinoic acid, Trans-Retinoic acid, Tretinoin, Vesanoid, Vitamin A acid

  Your Renova review